Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study - Concepedia

Concepedia

Publication | Open Access

Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study

DOI Full Paper Access

19

Citations

32

References

2022

Year

Dailong Li, Lu Xu, Jinxing Ji, Dan Bao, Juan Hu, Ying Qian, Yinjie Zhou, Zhuo Chen, Daojun Li, Xiaopeng Li,

Frontiers in Immunology

Abstract

https://ClinicalTrials.gov, identifier NCT04411706.

References

	Year	Citations

Page 1